BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 9622270)

  • 1. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
    Ward MR; Sasahara T; Agrotis A; Dilley RJ; Jennings GL; Bobik A
    Atherosclerosis; 1998 Apr; 137(2):267-75. PubMed ID: 9622270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
    Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.
    Smith JD; Bryant SR; Couper LL; Vary CP; Gotwals PJ; Koteliansky VE; Lindner V
    Circ Res; 1999 May; 84(10):1212-22. PubMed ID: 10347096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
    Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
    Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats.
    Miyazawa K; Kikuchi S; Fukuyama J; Hamano S; Ujiie A
    Atherosclerosis; 1995 Dec; 118(2):213-21. PubMed ID: 8770315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting.
    Ward MR; Agrotis A; Kanellakis P; Hall J; Jennings G; Bobik A
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):940-8. PubMed ID: 12067902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors.
    Watanabe S; Matsuda A; Suzuki Y; Kondo K; Ikeda Y; Hashimoto H; Umemura K
    Br J Pharmacol; 2000 May; 130(2):307-14. PubMed ID: 10807667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty.
    Wang X; Louden C; Ohlstein EH; Stadel JM; Gu JL; Yue TL
    Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1365-72. PubMed ID: 8911275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAS-301, an inhibitor of smooth muscle cell migration and proliferation, inhibits intimal thickening after balloon injury to rat carotid arteries.
    Muranaka Y; Yamasaki Y; Nozawa Y; Terakawa H; Tanahashi Y; Oda N; Satoh A; Asao T; Miyake H; Matsuura N
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1280-6. PubMed ID: 9618434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture.
    Miyazawa K; Hamano S; Ujiie A
    Br J Pharmacol; 1996 Jun; 118(4):915-22. PubMed ID: 8799562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.
    Ma X; Labinaz M; Goldstein J; Miller H; Keon WJ; Letarte M; O'Brien E
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2546-52. PubMed ID: 11116051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes.
    Bonnet F; Cao Z; Cooper ME; Cox AJ; Kelly DJ; Gilbert RE
    Diabetes Metab; 2003 Sep; 29(4 Pt 1):386-92. PubMed ID: 14526266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1 mRNA inhibits neointima formation in rat carotid artery after balloon injury.
    Ando H; Fukuda N; Kotani M; Yokoyama Si; Kunimoto S; Matsumoto K; Saito S; Kanmatsuse K; Mugishima H
    Eur J Pharmacol; 2004 Jan; 483(2-3):207-14. PubMed ID: 14729108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery.
    Shiota N; Okunishi H; Takai S; Mikoshiba I; Sakonjo H; Shibata N; Miyazaki M
    Circulation; 1999 Mar; 99(8):1084-90. PubMed ID: 10051304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory Effect of Tranilast on Transforming Growth Factor-Beta-Induced Protein in Granular Corneal Dystrophy Type 2 Corneal Fibroblasts.
    Kim TI; Lee H; Hong HK; Kim KS; Choi SI; Maeng YS; Kim EK
    Cornea; 2015 Aug; 34(8):950-8. PubMed ID: 26020822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular types I and II transforming growth factor-beta receptor expression: differential dependency on tyrosine kinases during induction by TGF-beta.
    Ward MR; Agrotis A; Jennings G; Bobik A
    FEBS Lett; 1998 Jan; 422(2):197-200. PubMed ID: 9490005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
    Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M
    Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells.
    Hishikawa K; Nakaki T; Hirahashi J; Marumo T; Saruta T
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):200-7. PubMed ID: 8856474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of vascular smooth muscle cell integrin expression by transforming growth factor beta1 and by platelet-derived growth factor-BB.
    Janat MF; Argraves WS; Liau G
    J Cell Physiol; 1992 Jun; 151(3):588-95. PubMed ID: 1295906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.
    Lan W; Yang F; Li Z; Liu L; Sang H; Jiang Y; Xiong Y; Zhang R
    J Vasc Surg; 2016 Oct; 64(4):1074-83. PubMed ID: 26054589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.